HNRNPAB and breast cancer: Survival curve analysis illustrated that the higher HNRNPAB level was remarkably correlated with shorter relapse-free survival (RFS), overall survival (OS), distant metastasis-free survival (DMFS), disease-free survival (DFS), and disease-specific survival (DSS) in BC, thus suggesting that HNRNPAB expression might be predictive of clinical outcomes in BC patients (see Figure 3 and Table 3).